Dynamics of daily blood pressure monitoring in hypertensive patients with obesity exposed to combined anthihypertensive therapy
DOI:
https://doi.org/10.14739/2310-1210.2013.5.18766Keywords:
hypertonic disease, obesity, daily blood pressure monitoring, combined antihypertensive therapyAbstract
The study of the features of daily monitoring of blood pressure in patients with essential hypertension by obesity compared with patients with essential hypertension without excess weight was done. Combined therapy with amlodipine and olmesartan leads to a signifi cant decrease in mean integral indicators and improve the circadian blood pressure.
References
Aneja A. Hypertension and obesity / A. Aneja, F. El-Atat, S.I. McFarlane, J.R. Sowers // Recent Progr. Horm. Res. – 2004. – Vol. 59. – P. 169–205.
Arbeeny C.M. Addressing the unmet medical need for safe and effective weight loss therapies / С. М. Arbeeny // Obes Res. – 2004. – V. 12, №8. – Р. 1191–1196.
Гуревич М.А. Место современных диуретиков в лечении артериальной гипертонии у пациентов с ожирением / А.М. Гуревич // Справочник поликлинического врача. – 2010. – №88. – С. 43–46.
Федорова Е.Ю. Механизмы прогрессирования поражения почек при ожирении / Е.Ю. Федорова, И.М. Кутырина // Нефрология и диализ. – Т. 8, №2.
Kramer H. Screening for kidney disease in adults with diabetes / H. Kramer H, M.E. Molitch // Diabetes Care. – 2005. – V. 28, №7. – Р. 1813–1816.
Rabmouni K. Obesity – associated Hypertension. New insights into mechanisms / K. Rabmouni, M.L.G. Correia, W.G. Haynes [et al.] // Hypertension. – 2005. – V. 45. – P. 9–14.
Братусь В.В. Ожирение, инсулинорезистентность, метаболический синдром: фундаментальные и клинические аспекты / В.В. Братусь, Т.В. Талева, В.А. Шумаков. – К.: Четверта хвиля, 2009. – 416 с.
Lassegue B. Reactive oxygen species in hypertension. An update / Lassegue B., Griendling KK. // AJH. – 2004. – V. 17. – P. 852–860.
Kuo J. Inhibition of NO sintesis enhances chronic cardiovascular and renal actions of leptin / Kuo J., Jones O.B., Hall J.E. // Hypertens. – 2001. – V. 37. – P. 670–676.
Лутай М.И. Роль дисфункции эндотелия, воспаления и дислипидемии в атеросклерозе / М.И. Лутай, И.П. Голикова, В.А.Слободской // Укр. Кард. Журнал. – 2007. – №5. – С. 37–42.
Ceconi C. Differences in the effect of angiotensin converting enzyme inhibitors on the rate on the rate of endothelial cell apoptosis: in vitro and in vivo studies / C. Ceconi, G. Francolini [et al.] // Cardiovasc. Drug Ther. – 2007. – V. 21. – P. 423–429.
ADVANCE Collaborative Group. Effects of fi xed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial / ADVANCE Collaborative Group // Lancet. – 2007. – V. 370. – P. 828–840.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
